SMTL ID : 6xlo.1

Crystal structure of bRaf in complex with inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.49 Å

Oligo State

homo-dimer

Ligands

2 x V5J: 3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide(Non-covalent)

V5J.1: 22 residues within 4Å: Chain A: I.28, V.36, A.46, V.47, K.48, E.66, V.69, L.70, L.79, I.92, T.94, Q.95, W.96, C.97, I.137, H.139, F.148, I.157, G.158, D.159, F.160, K.166 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:A.46, A:K.48, A:E.66, A:V.69, A:L.70, A:L.79, A:I.92, A:T.94, A:I.137, A:D.159, A:K.166 Hydrogen bonds: A:E.66, A:C.97, A:D.159 V5J.3: 20 residues within 4Å: Chain B: I.28, V.36, A.46, V.47, K.48, E.66, V.69, L.70, L.79, I.92, T.94, Q.95, W.96, C.97, H.139, F.148, I.157, G.158, D.159, F.160 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:A.46, B:K.48, B:E.66, B:V.69, B:L.70, B:L.79, B:I.92, B:T.94, B:D.159 Hydrogen bonds: B:E.66, B:C.97, B:D.159 pi-Stacking: B:F.160, B:F.160

1 x IOD: IODIDE ION(Non-functional Binders)

IOD.2: 4 residues within 4Å: Chain A: Q.61, N.65, S.167, R.168 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huestis, M.P. et al., Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3 H )-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor. J.Med.Chem. (2021)

Release Date

2021-05-26

Peptides

Serine/threonine-protein kinase B-raf: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Serine/threonine-protein kinase B-raf

Related Entries With Identical Sequence